Results 51 to 60 of about 11,158 (184)

Perfil clinicopatológico dos pacientes com doença bolhosa auto-imune atendidos no ambulatório de dermatoses bolhosas do Hospital Universitário- UFSC no período de janeiro a agosto de 2009 [PDF]

, 2009
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Vieira, Adriana
core  

Quality of life index in autoimmune bullous dermatosis patients [PDF]

Anais Brasileiros de Dermatologia, 2015
BACKGROUND: Autoimmune bullous dermatoses are complex diseases triggered by autoantibodies action against epidermal antigens or the dermoepidermal junction. Blisters and vesicles that evolve with erosion areas characterize them.
Mariana Álvares Penha, Joyce Godoy Farat, Hélio Amante Miot, Sílvia Regina Catharino Sartori Barraviera   +3 more
doaj   +1 more source

Navigating the Complexities of Pemphigus Vulgaris: A Comprehensive Iranian Study

Immunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
We conducted a cross‐sectional analysis of 63 patients diagnosed with pemphigus vulgaris, confirmed by biopsy. Information was collected via telephone interviews. The research aimed to assess the demographic characteristics, initial symptoms, diagnosis delays, and treatment outcomes of the participants.
Delaram Moosavi, Seyed Mohammad Mahdi Khadem, Afsaneh Sadeghzadeh Bazargan, Kambiz Kamyab Hesari, Mehrnaz Azh, Hamed Zarei Sharif, Nasrin Shayanfar, Azadeh Goodarzi   +7 more
wiley   +1 more source

A Cross-sectional Study of Clinical, Histopathological and Direct Immunofluorescence Spectrum of Vesiculobullous Disorders [PDF]

Journal of Clinical and Diagnostic Research, 2013
Background: Accurate diagnosis of vesiculobullous lesions of skin requires evaluation of clinical, histopathologic and immunofluorescence findings. Methods: A cross-sectional study of 68 patients to evaluate the clinical, histopathological and direct
Arundhathi S., Ragunatha S., Mahadeva K.C.   +2 more
doaj   +1 more source

A comparative study of expression of Fc receptors in relation to the autoantibody-mediated immune response and neutrophil elastase expression in autoimmune blistering dermatoses

Polish Journal of Pathology, 2017
Here we investigated the cutaneous CD32A and CD89 expression in relation to the neutrophil elastase (NE) expression and serum level of anti-desmoglein 1 and 3 (DSG1/DSG3) IgG in pemphigus, anti-BP180/BP230 IgG in bullous pemphigoid (BP), anti-gliadin ...
Justyna Gornowicz-Porowska, Agnieszka Seraszek-Jaros, Monika Bowszyc-Dmochowska, Elżbieta Kaczmarek, Paweł Pietkiewicz, Paweł Bartkiewicz, Marian Dmochowski   +6 more
doaj   +1 more source

Retrospective analysis of autoimmune bullous diseases in Middle Franconia

Frontiers in Immunology, 2023
IntroductionAutoimmune bullous diseases (AIBDs) are a group of rare cutaneous disorders affecting cornified skin and mucous membranes. They are characterized by tense or flaccid blistering and erosions due to autoantibodies against desmosomal and ...
Lukas Sollfrank, Lukas Sollfrank, Valerie Schönfelder, Valerie Schönfelder, Micheal Sticherling, Micheal Sticherling   +5 more
doaj   +1 more source

Noninvasive Imaging Techniques as Modern Diagnostic Tools in Desquamative Gingivitis: Focus on RCM, OCT, and LC‐OCT

Skin Research and Technology, Volume 32, Issue 1, January 2026.
ABSTRACT Background Desquamative gingivitis is a clinical condition characterized by erythema, blisters, and erosions within the gingiva. It may be a manifestation of oral lichen planus or autoimmune bullous diseases, such as pemphigus vulgaris and mucous membrane pemphigoid. The identification of the cause of desquamative gingivitis typically involves
Urszula Fałkowska, Aneta Durmaj, Carolyn Szwed, Marta Kurzeja, Joanna Czuwara, Dorota Olczak‐Kowalczyk, Lidia Rudnicka, Małgorzata Olszewska   +7 more
wiley   +1 more source

The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19)

Vestnik Dermatologii i Venerologii, 2021
The article describes a clinical case of vaccination with the drug "Kovivac" of a patient of an older age group with an established diagnosis of bullous pemphigoid.
Andrey A. Martynov, Anna V. Vlasova
doaj   +1 more source

JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova, Yuliya Kolesova, Natalia Teplyuk, Ekaterina Grekova, Leyi Ni, Alina Mardanova, Karim Karray, Anastasiia Tikhonova, Anfisa Lepekhova, Jaime Piquero-Casals   +9 more
wiley   +1 more source

Real‐World Study on the Efficacy and Safety Assessment of Ultralow‐Dose Rituximab in the Treatment of Pemphigus

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Objective To evaluate the efficacy and safety of ultralow‐dose (200 mg) versus low‐dose (500 mg) rituximab, each combined with glucocorticoids, in the treatment of pemphigus during the 6‐month follow‐up period. Methods This nonrandomized controlled study enrolled 26 pemphigus patients.
Shurui Wu, Han Zhang, Yuhan Ji, Lin Shen, Fangfang Wei, Liang Ma, Biwen Lin, Cuihao Song, Chengxin Li   +8 more
wiley   +1 more source